# Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

> **NCT05758948** · — · UNKNOWN · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 101 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue

## Key facts

- **NCT ID:** NCT05758948
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-07-05
- **Primary completion:** 2010-10-05
- **Final completion:** 2023-06
- **Target enrollment:** 101 (ESTIMATED)
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758948, "Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05758948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*